$176.50
1.781.02%
At close: -
$177.10
0.600.34%
After Hours: Dec 20, 5:23 PM EDT
Comments
Loading...
BeiGene (NASDAQ:BGNE) Stock Quotes, Forecast and News Summary
BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BeiGene (BGNE) stock?
You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.
Who are BeiGene (BGNE) competitors?
Other companies in BeiGene’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for BeiGene (BGNE) stock?
BeiGene has a consensus price target of $267.70.
What is the current price for BeiGene (BGNE)?
The stock price for BeiGene (NASDAQ: BGNE) is $177.1 last updated December 20, 2024 at 5:23 PM EST.
Does BeiGene (BGNE) pay a dividend?
There are no upcoming dividends for BeiGene.
When is BeiGene (NASDAQ:BGNE) reporting earnings?
BeiGene’s Q4 earnings are confirmed for Monday, February 24, 2025.
Is BeiGene (BGNE) going to split?
There is no upcoming split for BeiGene.
What sector and industry does BeiGene (BGNE) operate in?
BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.